Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders.

Lim K, See YM, Lee J.

Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):301-312. doi: 10.9758/cpn.2017.15.4.301. Review.

2.

Training and Practices of Cannabis Dispensary Staff.

Haug NA, Kieschnick D, Sottile JE, Babson KA, Vandrey R, Bonn-Miller MO.

Cannabis Cannabinoid Res. 2016 Dec 1;1(1):244-251. doi: 10.1089/can.2016.0024. eCollection 2016.

3.

Neurological Aspects of Medical Use of Cannabidiol.

Mannucci C, Navarra M, Calapai F, Spagnolo EV, Busardò FP, Cas RD, Ippolito FM, Calapai G.

CNS Neurol Disord Drug Targets. 2017;16(5):541-553. doi: 10.2174/1871527316666170413114210. Review.

PMID:
28412918
4.

Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?

Giacoppo S, Mazzon E.

Neural Regen Res. 2016 Dec;11(12):1896-1899. doi: 10.4103/1673-5374.197125. Review.

5.

Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.

Suryadevara U, Bruijnzeel DM, Nuthi M, Jagnarine DA, Tandon R, Bruijnzeel AW.

Curr Neuropharmacol. 2017;15(6):800-814. doi: 10.2174/1570159X14666161101095325. Review.

6.

Therapeutic approach to pain in neurodegenerative diseases: current evidence and perspectives.

de Tommaso M, Kunz M, Valeriani M.

Expert Rev Neurother. 2017 Feb;17(2):143-153. doi: 10.1080/14737175.2016.1210512. Epub 2016 Jul 26. Review.

PMID:
27400329
7.

Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Bedlack RS, Joyce N, Carter GT, Paganoni S, Karam C.

Neurol Clin. 2015 Nov;33(4):909-36. doi: 10.1016/j.ncl.2015.07.008. Epub 2015 Sep 8. Review.

8.

Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.

Pryce G, Baker D.

Handb Exp Pharmacol. 2015;231:213-31. doi: 10.1007/978-3-319-20825-1_7. Review.

PMID:
26408162
9.

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R.

Neurosci Biobehav Rev. 2015 Aug;55:294-321. doi: 10.1016/j.neubiorev.2015.04.015. Epub 2015 May 6. Review.

10.

Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.

Belendiuk KA, Baldini LL, Bonn-Miller MO.

Addict Sci Clin Pract. 2015 Apr 21;10:10. doi: 10.1186/s13722-015-0032-7. Review.

11.

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.

Chiurchiù V, Leuti A, Maccarrone M.

J Neuroimmune Pharmacol. 2015 Jun;10(2):268-80. doi: 10.1007/s11481-015-9584-2. Epub 2015 Jan 20. Review.

PMID:
25601726
12.

HIV peripheral neuropathy.

Gabbai AA, Castelo A, Oliveira AS.

Handb Clin Neurol. 2013;115:515-29. doi: 10.1016/B978-0-444-52902-2.00029-1.

PMID:
23931799
13.

[Marihuana and cannobinoids as medicaments].

Tkaczyk M, Florek E, Piekoszewski W.

Przegl Lek. 2012;69(10):1095-7. Review. Polish.

PMID:
23421098
14.

ALSUntangled No. 16: cannabis.

ALSUntangled Group.

Amyotroph Lateral Scler. 2012 Jun;13(4):400-4. doi: 10.3109/17482968.2012.687264. Review. No abstract available.

PMID:
22632446
15.

Cannabis use in palliative care - an examination of the evidence and the implications for nurses.

Green AJ, De-Vries K.

J Clin Nurs. 2010 Sep;19(17-18):2454-62. doi: 10.1111/j.1365-2702.2010.03274.x. Review.

PMID:
20920073
16.

Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.

Carter GT, Abood ME, Aggarwal SK, Weiss MD.

Am J Hosp Palliat Care. 2010 Aug;27(5):347-56. doi: 10.1177/1049909110369531. Epub 2010 May 3.

PMID:
20439484
17.

Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.

Weydt P, Hong S, Witting A, Möller T, Stella N, Kliot M.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Sep;6(3):182-4.

PMID:
16183560
18.

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT.

Am J Hosp Palliat Care. 2004 Mar-Apr;21(2):95-104.

PMID:
15055508
19.

Marijuana in the management of amyotrophic lateral sclerosis.

Carter GT, Rosen BS.

Am J Hosp Palliat Care. 2001 Jul-Aug;18(4):264-70. Review.

PMID:
11467101

Supplemental Content

Loading ...
Support Center